Acute myeloid leukemia
Conditions
Interventions
Venetoclax treatment observation group:None
Sponsors
Affiliated Hospital of Southwest Medical University
Eligibility
Sex/Gender
All
Age
14 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. All patients treated with Venetoclax during hospitalization in our hospital from January 2020 to June 2024; 2. Over 14 years old; 3. Blood levels of Venetoclax were tested at least once during hospitalization.
Exclusion criteria
Exclusion criteria: 1.There are patients who have purchased Venetoclax through non-official channels; 2.Patients who do not follow the doctor's advice or do not take the medicine regularly during the medication period; 3. Patients with concurrent pregnancies or other conditions that are not suitable for inclusion; 4.Patients who used other drugs or foods that clearly affected the exposure level of Venetoclax during the medication period;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area under time-concentration Curve; | — |
Secondary
| Measure | Time frame |
|---|---|
| Degree of disease remission;Adverse reaction; | — |
Countries
China
Contacts
Public ContactMaolin Chen
Affiliated Hospital of Southwest Medical University
Outcome results
None listed